Your session is about to expire
← Back to Search
Cisplatin-IMRT for Squamous Cell Carcinoma ((UPCI)13-056 Trial)
(UPCI)13-056 Trial Summary
This trial is testing which chemotherapy combo is more effective for treating HNSCC, as well as the side effects of the combos.
(UPCI)13-056 Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.(UPCI)13-056 Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
What medical conditions are typically addressed with the combination therapy of Cisplatin and IMRT?
"The treatment regimen involving Cisplatin-IMRT is valuable in managing metastatic bladder cancer. It also shows promise in addressing advanced directives, small cell lung cancer, and advanced testicular cancer."
Can you provide information on previous research studies using Cisplatin-IMRT?
"Currently, there are 313 active investigations exploring the combination of Cisplatin and IMRT, with a substantial portion (114 trials) in Phase III. Although numerous studies on this treatment approach are based in Zhuhai, Guangdong, a vast network of 6949 sites worldwide is involved in researching Cisplatin-IMRT."
What is the overall participant count in this clinical study?
"Recruitment for this clinical study has ceased. The trial was first shared on 12/1/2013 and last revised on 4/7/2020. For individuals interested in other research opportunities, there are currently 2663 active trials seeking participants with squamous cell carcinoma and 313 ongoing studies focusing on Cisplatin-IMRT actively enrolling volunteers."
What risks are associated with the administration of Cisplatin-IMRT in individuals?
"Our team at Power has assessed the safety of Cisplatin-IMRT to be a 2 on the scale, reflecting the Phase 2 trial status. At this stage, there is existing data supporting its safety profile but not yet confirming its efficacy."
Are researchers currently enrolling participants for this medical study?
"At present, there are no ongoing patient recruitments for this particular research. The clinical trial was initially published on December 1st, 2013 and last revised on April 7th, 2020. For those interested in exploring other opportunities, there are currently a total of 2663 active clinical trials seeking participants with squamous cell carcinoma and another 313 studies focused on Cisplatin-IMRT actively enrolling patients."
Share this study with friends
Copy Link
Messenger